rfhg_232716.1

Basic information about the TSS

---

TSS ID: rfhg_232716.1 Species: human Chr: chrM		Start: 7784 End: 7784 Strand: +
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:
Category:

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK026536:-68 GeneID: 107075310 HGNC/MGI_ID: HGNC:52028 UniProt_ID: Nearer transcript ids and distances: X55654:-75 Y17175:108 AY211920:-141 AB019563:-177 ENST00000361739.1:-198 X15759:-198 BC013387:-198 BC013388:-198 BC013390:-198 BC013391:-198 LP790438:-198 LP790411:-198 LP790412:-198 LP803417:-198 LP803418:-198 LY485908:-198 LY485909:-198 LP790403:-198 LP790404:-198 LP790405:-198 LP803409:-198 LP803410:-198 LP803411:-198 LY485900:-198 LY485901:-198 LY485902:-198 X64709:444 view more...

Gene_name: MT-CO2 pseudogene 12 Gene_symbol: MTCO2P12 Gene_synonyms: Gene_source: HGNC:52028

TATA-Box annotation

---

Distance to TSS:	-270
Nearest PromoterID:	NR_162149
Entrez ID:	113219467
Nearest Unigene:
Nearest Refseq:	NR_162149
Nearest Ensembl:
Gene Name:	MT-CO2 pseudogene 12
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MTCO2P12 p2@MTCO2P12 p3@MTCO2P12
Sample		p1@MTCO2P12	p2@MTCO2P12	p3@MTCO2P12
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	133.83	13.64	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	139.60	14.16	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	184.03	16.20	2.89
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	99.80	9.98	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	103.93	8.55	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	112.99	11.05	3.49
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	141.41	8.93	5.01
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	101.25	13.56	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	91.04	12.18	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	117.08	12.17	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	119.65	12.13	4.85
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	82.12	13.82	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	75.44	5.64	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	93.97	4.06	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	87.82	2.63	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	113.42	8.55	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	114.88	4.80	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	173.37	10.97	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	106.63	10.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	103.65	5.87	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	72.71	5.61	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	111.69	5.01	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	59.98	4.27	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	94.40	5.82	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	136.73	7.22	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	125.02	6.33	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	143.96	9.89	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	89.11	3.77	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	117.43	5.49	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	84.51	5.79	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	91.48	7.33	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	119.18	5.67	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	136.96	13.93	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	78.84	7.26	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	115.75	6.73	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	108.84	7.47	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	118.74	7.36	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	80.59	5.24	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	82.11	9.18	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	93.38	6.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	100.46	4.94	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	71.59	6.15	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	99.96	4.43	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	81.82	5.59	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	84.53	5.62	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	100.50	7.91	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	74.85	6.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	100.74	5.07	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	90.24	6.70	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	78.86	4.65	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	114.16	9.63	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	170.78	9.56	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	293.84	83.95	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	104.68	11.36	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	83.84	9.28	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	341.45	62.92	32.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	222.27	30.77	16.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	92.05	10.37	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	116.26	14.13	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	211.54	22.63	7.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	81.79	15.51	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	107.67	7.85	4.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	373.39	73.25	37.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	189.93	26.50	13.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	112.10	28.27	14.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	103.30	11.36	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	258.62	32.33	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	221.13	47.38	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	86.29	7.80	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	111.08	9.42	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	50.66	8.91	4.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	131.81	16.56	8.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	90.64	11.14	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	89.89	7.95	3.97
Adipocyte - breast, donor1	11376-118A8	39.28	2.53	0.95
Adipocyte - breast, donor2	11327-117E4	109.41	7.54	0.96
Adipocyte - omental, donor1	11473-119C6	31.30	1.15	0.38
Adipocyte - omental, donor2	11474-119C7	49.33	6.73	0.75
Adipocyte - omental, donor3	11475-119C8	51.91	10.05	1.00
Adipocyte - perirenal, donor1	11476-119C9	38.28	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	5.50	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	23.03	4.06	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.94	0.87	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	11.34	1.17	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	21.88	1.29	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	25.93	2.79	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	36.44	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	60.81	2.49	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	37.76	1.29	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	34.66	2.67	4.27
Adipocyte differentiation, day08, donor4	13029-139E5	55.09	5.01	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	51.99	3.33	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	38.43	1.76	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	46.47	3.93	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	52.98	2.74	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	21.44	1.55	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	27.61	4.66	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	24.11	1.44	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.63	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.47	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	13.71	1.96	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	107.38	9.88	3.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	92.04	7.38	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	203.32	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	89.98	7.17	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	123.94	8.85	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	79.21	3.96	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	62.70	3.90	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	76.21	4.85	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	100.96	5.34	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	77.96	4.14	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	89.26	2.90	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	125.38	10.03	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.14	0.49	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	79.16	4.09	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.24	2.26	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	73.40	3.21	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	47.61	2.65	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	53.19	3.21	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	75.11	4.88	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	45.11	2.32	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	105.66	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	84.96	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	46.66	2.74	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	96.48	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	81.07	3.40	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	39.46	1.52	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	144.15	12.11	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	77.52	2.85	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.53	2.35	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	41.04	1.55	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	74.60	5.63	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	72.03	3.86	3.54
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	47.80	3.57	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	71.36	6.43	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	53.89	2.71	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	141.37	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	93.07	7.12	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	115.63	7.39	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	40.03	3.18	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	80.70	6.04	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.71	3.60	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	49.88	3.19	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	113.37	7.56	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	41.03	2.20	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	118.13	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	84.50	6.34	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	50.39	2.36	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.16	3.61	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	75.08	4.37	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	58.62	2.76	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	311.14	10.20	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	35.34	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	47.48	2.06	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	54.77	1.84	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	86.04	5.74	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	44.79	2.22	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	97.65	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	49.30	2.77	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.84	2.65	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	45.79	2.54	0.36
Astrocyte - cerebellum, donor1	11500-119F6	19.40	1.47	0.12
Astrocyte - cerebellum, donor2	11580-120F5	37.14	3.77	1.20
Astrocyte - cerebellum, donor3	11661-122F5	9.02	0.63	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	25.10	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	69.40	3.24	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	28.34	2.83	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	111.82	5.62	2.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	106.74	6.89	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	130.41	5.12	3.87
Basophils, donor1	12241-129G9	10.98	0.52	0.52
Basophils, donor2	12242-129H1	10.82	0.00	0.00
Basophils, donor3	12243-129H2	11.17	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	22.64	2.16	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	24.23	3.66	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	11.93	3.14	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	22.25	2.70	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	16.35	2.07	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	60.82	4.68	1.80
Burkitt's lymphoma cell line:DAUDI	10422-106C8	26.90	2.58	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	144.63	9.55	3.73
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.47	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	42.32	3.34	1.67
CD14+ Monocytes, donor3	11381-118B4	34.03	5.05	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	14.15	1.42	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.40	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.92	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	44.23	3.04	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	26.25	1.81	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	22.74	1.90	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	38.17	4.02	2.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	28.43	2.76	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	31.73	4.96	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	50.52	2.55	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.38	2.67	1.78
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.55	2.18	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	25.05	1.64	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.20	3.17	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	17.75	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	57.57	2.23	2.23
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	29.73	2.39	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	26.44	1.87	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	48.04	4.12	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.32	2.04	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	28.37	3.49	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	35.78	3.23	3.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	45.88	2.79	1.57
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	29.46	2.52	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	57.32	3.12	2.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	26.42	2.82	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	34.66	3.95	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	74.98	3.66	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	67.27	5.58	3.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	23.28	3.02	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	51.19	4.50	3.28
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.24	3.48	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	27.61	3.02	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	25.07	1.96	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	18.71	1.39	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	16.03	0.87	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	26.94	2.02	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	14.67	1.22	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	32.33	2.01	1.78
CD14-CD16+ Monocytes, donor1	11790-124B8	18.63	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	21.96	2.42	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	20.84	2.11	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	27.18	1.60	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	6.59	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	82.19	9.04	3.29
CD19+ B Cells, donor2	11624-122B4	103.01	15.96	2.90
CD19+ B Cells, donor3	11705-123B4	82.79	11.11	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.82	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	9.04	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	11.24	2.25	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	31.56	1.50	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	11.95	1.35	0.23
CD4+ T Cells, donor1	11225-116C1	26.07	1.79	2.50
CD4+ T Cells, donor2	11306-117C1	106.55	4.90	1.84
CD4+ T Cells, donor3	11382-118B5	44.22	5.18	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.67	2.55	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	27.18	2.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	26.45	1.72	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.22	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	75.81	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.79	1.01	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	45.59	2.54	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.46	3.06	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	17.48	1.79	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.67	1.75	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	44.44	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	53.55	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	53.40	3.74	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	59.47	3.68	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	30.46	2.18	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	3.22	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	46.62	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	21.88	1.67	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	20.15	1.73	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.22	1.26	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	15.17	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	10.40	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	38.35	4.79	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	13.86	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	9.23	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	8.37	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	5.54	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	10.31	1.96	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	10.78	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	11.46	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	4.15	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	26.52	1.64	0.98
CD8+ T Cells, donor2	11307-117C2	74.34	3.75	2.63
CD8+ T Cells, donor3	11383-118B6	48.23	4.80	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	212.19	14.45	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	302.19	21.81	3.12
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	249.79	13.41	3.01
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	179.53	13.81	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	307.66	21.84	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	190.55	18.65	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	149.06	9.56	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	148.71	11.05	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	175.65	11.96	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	303.69	17.21	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	256.81	11.91	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	174.78	9.86	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	121.26	10.94	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	112.04	7.74	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	155.89	16.41	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	121.01	11.16	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	139.26	12.08	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	122.33	8.25	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	144.19	8.56	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	157.47	13.23	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	138.17	11.54	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	214.95	8.03	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	197.45	13.40	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	273.07	25.72	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	203.95	15.26	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	235.01	26.58	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	267.47	20.04	1.00
Cardiac Myocyte, donor1	11525-119I4	111.49	7.31	3.66
Cardiac Myocyte, donor2	11605-120I3	30.14	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	8.84	0.53	0.11
Chondrocyte - de diff, donor1	11261-116G1	109.20	12.83	4.85
Chondrocyte - de diff, donor2	11338-117F6	12.08	2.13	0.36
Chondrocyte - de diff, donor3	11410-118E6	39.82	3.30	0.57
Chondrocyte - re diff, donor2	11339-117F7	11.64	5.37	0.90
Chondrocyte - re diff, donor3	11411-118E7	12.54	2.02	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	45.79	1.84	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	61.14	2.78	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	41.15	3.54	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.56	3.12	0.09
Corneal Epithelial Cells, donor1	11526-119I5	28.76	3.51	0.88
Corneal Epithelial Cells, donor2	11606-120I4	102.38	3.41	4.55
Corneal Epithelial Cells, donor3	11687-122I4	38.86	2.05	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	20.64	2.64	1.98
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.34	3.15	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	34.02	3.35	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	12.64	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.88	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	5.32	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	4.17	1.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	24.60	4.81	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	2.75	0.79
Endothelial Cells - Artery, donor1	11264-116G4	13.38	1.45	0.00
Endothelial Cells - Artery, donor2	11341-117F9	26.82	0.94	0.24
Endothelial Cells - Artery, donor3	11413-118E9	4.21	0.88	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.96	1.33	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.58	1.97	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	17.83	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	14.46	1.56	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	25.61	2.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	21.49	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	32.80	1.86	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.42	3.26	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.43	1.95	1.22
Endothelial Cells - Vein, donor1	11267-116G7	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.18	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.30	1.41	0.63
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	1.65	0.00
Eosinophils, donor3	12246-129H5	10.70	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	29.56	0.98	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	70.73	10.40	8.32
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	34.07	1.64	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	61.31	5.36	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.28	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.29	1.70	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.32	0.68	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	42.50	3.69	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	96.96	6.59	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	26.91	2.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	14.97	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	6.06	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	13.88	1.26	0.16
Fibroblast - Cardiac, donor4	11452-119A3	3.94	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	15.48	1.02	0.63
Fibroblast - Cardiac, donor6	11460-119B2	16.98	0.91	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.85	1.21	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.63	5.18	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	74.70	7.32	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	19.14	0.92	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	1.02	0.00
Fibroblast - Dermal, donor1	11269-116G9	29.82	2.82	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.13	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	50.17	4.71	1.57
Fibroblast - Dermal, donor4	11450-119A1	15.04	1.70	0.34
Fibroblast - Dermal, donor5	11454-119A5	23.20	1.92	0.87
Fibroblast - Dermal, donor6	11458-119A9	26.48	2.27	0.32
Fibroblast - Gingival, donor1	11237-116D4	14.58	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	25.94	1.31	0.79
Fibroblast - Gingival, donor2	11318-117D4	70.37	3.95	0.40
Fibroblast - Gingival, donor3	11394-118C8	13.63	0.87	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	6.23	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.61	1.23	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	39.44	1.87	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	50.71	2.30	1.89
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.63	2.63	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	56.59	2.73	1.77
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.55	2.74	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.96	1.47	0.73
Fibroblast - Lung, donor1	11270-116H1	8.16	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	89.53	8.95	1.49
Fibroblast - Lung, donor3	11419-118F6	14.35	0.84	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	24.16	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	12.59	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.12	1.62	2.03
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.02	2.52	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	49.30	2.88	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	6.12	0.92	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.61	1.91	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.00	1.08	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.67	0.70	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.60	0.77	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.73	1.83	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.70	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.81	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	5.75	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.37	1.24	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	36.26	1.97	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	123.95	13.24	4.21
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.29	1.62	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1.01	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	29.04	2.30	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	165.42	8.42	2.41
Fibroblast - skin normal, donor2	11561-120D4	20.90	1.21	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2.42	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.91	0.91	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.83	1.54	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	136.63	21.35	3.94
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	26.10	2.34	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	32.22	2.02	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	174.70	17.56	5.65
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	32.25	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.90	1.56	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	39.04	3.90	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.26	1.79	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	94.16	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	95.71	6.38	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	242.47	14.26	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	67.84	2.48	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.44	2.51	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	112.74	8.12	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.57	3.97	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	24.46	1.96	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	299.83	13.27	8.84
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	24.59	3.53	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.34	3.45	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	45.67	3.76	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.85	2.73	1.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.79	2.63	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.35	3.46	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	38.79	2.05	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	25.04	2.49	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	23.61	1.75	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	40.48	2.07	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.63	1.91	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.58	2.46	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	41.94	3.83	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.00	3.39	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.45	1.51	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.45	1.87	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.59	3.07	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.45	2.32	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.63	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.73	2.25	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	36.93	1.86	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.98	3.46	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.86	2.84	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	45.19	2.87	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	30.38	3.69	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.53	2.76	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	52.28	4.81	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.28	3.41	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.04	2.06	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	65.68	4.26	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.22	3.66	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.66	3.29	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	58.35	3.93	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.46	3.52	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	65.78	3.48	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.45	3.67	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.51	3.24	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	42.83	4.34	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	58.62	3.87	2.40
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	72.15	4.82	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	60.50	5.95	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	43.14	3.17	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	42.37	2.82	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	38.38	3.81	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	49.37	4.78	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	40.68	3.24	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	46.24	4.91	2.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	28.79	1.56	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.63	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	63.65	8.76	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	4.95	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	76.97	5.03	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	192.54	6.42	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	78.25	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	73.23	3.25	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	98.01	7.41	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	206.60	13.33	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	78.30	3.36	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	80.73	5.23	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	99.82	7.55	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	95.42	5.73	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	67.59	4.42	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	41.76	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	64.72	5.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.37	3.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	96.57	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	83.67	6.63	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	76.40	5.06	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	110.64	21.07	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	67.27	3.08	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	54.44	3.59	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	23.41	2.01	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	51.24	2.31	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	103.39	6.85	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	2.48	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	61.81	5.19	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	76.04	7.85	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	28.49	2.03	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.59	9.17	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	55.75	4.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	84.99	3.54	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	65.35	2.92	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.87	3.51	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	125.46	11.02	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	113.41	5.37	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	89.77	3.40	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.02	3.33	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	58.67	4.12	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.15	1.67	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	56.74	2.67	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	47.60	2.36	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.80	2.28	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	59.14	3.50	1.53
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	40.40	3.22	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	33.80	2.37	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	56.17	4.61	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	53.35	3.77	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	39.09	3.52	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	35.26	2.24	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	142.77	2.64	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.57	2.12	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.84	1.22	0.17
Hepatocyte, donor1	11523-119I2	536.30	58.11	36.32
Hepatocyte, donor2	11603-120I1	317.81	23.70	21.55
Hepatocyte, donor3	11684-122I1	120.25	15.95	6.75
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	151.42	5.22	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	106.44	6.82	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	25.93	1.37	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	9.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	189.58	0.00	54.17
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	74.76	6.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	47.55	7.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	82.01	10.25	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	63.35	6.50	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	51.69	6.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	7.26	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	91.32	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	48.50	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	23.20	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	41.35	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	43.19	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	1.68	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	45.01	7.23	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.01	2.77	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	26.91	1.89	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	44.12	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	34.43	3.19	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	63.55	1.43	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	37.66	2.47	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	29.21	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	55.33	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	61.04	4.36	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	56.24	4.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	51.21	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	31.29	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	18.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	48.64	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	34.92	1.14	0.98
Keratinocyte - epidermal, donor2	11349-117G8	16.40	2.34	0.59
Keratinocyte - epidermal, donor3	11421-118F8	24.52	1.14	0.47
Keratinocyte - oral, donor1	11251-116E9	28.72	1.93	0.45
Keratocytes, donor1	11527-119I6	9.63	0.34	0.34
Keratocytes, donor2	11607-120I5	15.23	2.34	0.00
Keratocytes, donor3	11688-122I5	4.94	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	61.49	6.47	1.08
Lens Epithelial Cells, donor2	11609-120I7	19.95	1.50	0.58
Lens Epithelial Cells, donor3	11690-122I7	4.54	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.19	0.95	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	60.00	1.12	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	63.44	2.99	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	68.29	3.76	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	118.50	8.51	5.36
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	44.64	2.48	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	84.13	4.51	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	52.08	1.77	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	61.23	3.10	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	60.12	3.16	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.77	2.13	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	30.73	2.22	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	71.43	4.18	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	53.43	2.15	3.10
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	45.32	1.65	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	64.36	4.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	47.70	1.25	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	53.80	2.01	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	66.48	2.63	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	53.30	2.34	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	55.01	1.24	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	62.56	6.79	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	49.55	1.35	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	52.68	2.57	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	63.76	1.56	2.07
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	74.96	3.98	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.18	1.50	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	58.47	4.13	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	37.44	0.94	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	40.72	1.59	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	65.42	6.30	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	49.29	1.98	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	42.00	1.73	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	88.11	4.81	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	45.96	1.73	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	38.91	1.10	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	67.54	5.15	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	73.34	2.74	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	43.11	2.10	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	58.31	1.07	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	64.48	5.33	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.37	1.87	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	59.45	3.58	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.71	1.96	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	39.55	1.65	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.09	1.86	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	34.06	1.54	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.43	2.39	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	96.66	11.51	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	58.64	11.13	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	236.53	11.00	5.50
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	181.46	17.58	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	122.35	15.88	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	338.53	22.16	7.21
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	102.29	17.84	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	47.27	3.17	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	188.46	11.92	3.78
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	128.75	14.41	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	64.90	2.98	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	205.92	16.43	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	63.51	9.17	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	93.28	8.00	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	277.62	18.85	8.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	102.45	11.47	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	150.78	9.64	3.97
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	267.51	15.34	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	121.50	23.65	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	173.26	12.29	3.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	228.41	20.18	5.61
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	97.88	10.30	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	238.63	22.93	7.84
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	130.93	11.06	6.88
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	78.01	17.70	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	266.18	19.44	6.72
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	202.83	16.96	4.43
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	125.49	21.87	11.51
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	226.03	24.94	5.37
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	344.77	34.53	5.66
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	86.15	12.31	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	215.55	14.01	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	191.74	19.39	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	67.97	5.98	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	253.80	19.32	6.69
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	139.13	13.35	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	86.49	11.13	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	227.23	12.66	7.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	229.86	25.94	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	63.28	10.66	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	197.29	18.90	3.09
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	246.37	18.79	6.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	86.19	8.75	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	317.07	28.89	10.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	81.45	9.52	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	223.28	15.61	4.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	176.63	18.90	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	125.71	20.70	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	460.23	29.60	15.29
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	257.82	18.82	5.65
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	143.30	15.59	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	205.03	18.93	7.21
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	357.99	36.14	10.33
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	172.79	22.71	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	208.81	17.21	5.47
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	154.38	19.79	5.94
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	114.68	15.57	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	280.92	17.50	7.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	185.06	16.21	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	148.83	15.46	4.42
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	217.93	20.83	6.94
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	200.52	16.71	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	113.43	14.42	5.29
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	219.05	14.71	5.17
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	204.16	20.66	7.90
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	96.84	13.83	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	204.82	20.52	4.56
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	244.78	24.27	5.16
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	165.07	19.35	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	234.19	23.45	6.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	183.38	19.19	4.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	112.06	14.37	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	310.08	32.40	8.74
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	201.60	19.81	8.49
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	108.39	17.02	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	225.90	14.14	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	220.03	17.23	7.05
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	122.76	12.94	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	200.72	19.05	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	168.60	17.40	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	57.21	8.55	4.81
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	147.90	13.74	5.25
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	149.60	9.18	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	133.37	24.90	7.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	98.02	7.98	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	172.55	16.87	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	139.53	26.26	7.11
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	134.08	16.93	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	51.99	4.94	2.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	106.76	17.24	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	476.00	20.79	22.86
Macrophage - monocyte derived, donor1	11232-116C8	10.48	2.05	0.91
Macrophage - monocyte derived, donor2	11313-117C8	8.81	1.47	0.18
Macrophage - monocyte derived, donor3	11389-118C3	12.58	1.70	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.74	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	28.52	1.58	0.48
Mallassez-derived cells, donor3	11930-125I4	17.93	2.08	1.11
Mammary Epithelial Cell, donor1	11273-116H4	36.67	1.59	0.60
Mammary Epithelial Cell, donor2	11350-117G9	55.30	3.19	1.16
Mammary Epithelial Cell, donor3	11422-118F9	4.24	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	19.66	4.07	2.03
Mast cell, donor1	11563-120D6	46.82	3.24	1.84
Mast cell, donor2	11565-120D8	16.94	2.67	0.59
Mast cell, donor3	11566-120D9	7.43	2.70	1.13
Mast cell, donor4	11567-120E1	17.73	1.77	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	25.28	2.99	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	48.45	1.17	1.75
Mast cell, expanded, donor5	11939-126A4	13.65	0.92	0.34
Mast cell, expanded, donor8	11941-126A6	21.09	1.17	0.67
Melanocyte - dark, donor1	11502-119F8	21.79	1.29	0.50
Melanocyte - dark, donor2	11582-120F7	26.65	2.42	0.00
Melanocyte - dark, donor3	11663-122F7	29.77	1.67	0.65
Melanocyte - light, donor1	11274-116H5	69.82	7.05	3.76
Melanocyte - light, donor2	11351-117H1	53.91	11.60	6.82
Melanocyte - light, donor3	11423-118G1	18.21	3.47	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	60.91	7.50	2.50
Melanocyte, donor2 (MC+2)	12739-135I3	111.88	5.38	3.23
Melanocyte, donor3 (MC+3)	12837-137B2	109.28	8.04	1.61
Meningeal Cells, donor1	11493-119E8	8.68	1.36	0.62
Meningeal Cells, donor2	11573-120E7	20.25	2.20	0.44
Meningeal Cells, donor3	11654-122E7	18.09	0.49	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	6.56	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.69	1.51	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	35.16	2.15	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	27.95	1.91	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	48.25	2.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	35.60	1.32	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	20.46	1.46	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.78	1.84	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.25	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	28.62	1.86	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.31	1.32	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	41.54	5.34	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	3.20	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.41	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.69	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	30.50	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	13.51	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	44.44	3.90	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	47.28	3.69	1.97
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	47.11	3.83	3.83
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.15	4.96	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	49.99	3.32	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	46.05	1.50	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	52.60	5.12	6.98
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.73	2.64	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	51.08	2.77	2.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	100.88	21.24	4.42
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	74.85	3.80	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	39.05	4.24	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	3.68	5.52
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	36.06	5.66	3.28
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	3.35	5.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	40.90	4.01	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	50.62	1.90	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	38.45	7.60	2.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	41.86	1.47	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	1.22	1.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	40.98	4.29	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	34.23	4.67	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.22	2.41	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	23.83	5.07	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.73	2.17	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.41	2.65	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	1.09	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	46.61	4.32	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	83.25	4.40	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	47.05	7.01	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	38.54	1.75	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	2.21	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.20	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	35.45	4.71	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	41.37	3.76	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	36.19	2.81	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	1.66	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	33.48	4.22	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	19.62	4.17	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	4.62	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	5.69	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	23.49	0.97	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	29.80	2.07	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.72	1.29	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.27	1.27	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.08	3.47	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.16	3.59	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.91	1.27	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.26	0.96	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.02	2.43	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.31	0.76	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.01	2.27	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.89	2.21	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.05	2.65	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.89	2.02	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.36	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.42	1.49	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	150.68	26.37	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	53.56	5.26	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	56.81	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	21.94	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	51.45	4.88	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.17	1.33	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.37	0.90	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	61.88	4.42	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	71.09	7.69	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	253.56	24.89	7.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.91	2.67	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	81.14	19.32	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	121.19	9.09	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	64.51	5.06	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	48.96	3.18	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	1.62	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	101.20	7.55	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	163.12	22.84	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	104.55	9.50	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	25.10	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	27.58	2.15	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.29	3.66	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	76.76	6.01	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	52.59	9.60	21.70
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	114.85	5.51	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	4.79	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	58.48	2.72	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	95.56	18.38	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	48.55	5.44	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.97	7.44	3.02
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	47.56	4.32	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	38.47	6.52	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	211.56	44.54	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	73.46	7.45	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	92.57	6.50	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	82.29	2.49	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.60	2.78	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	36.45	2.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	101.31	13.26	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	61.83	4.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	132.91	26.58	28.22
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	48.79	3.09	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.27	5.29	3.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	73.14	4.92	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	71.25	11.49	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	50.45	5.14	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	299.71	22.42	15.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	136.54	25.28	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	32.53	5.12	2.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	82.14	10.16	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	88.77	5.46	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	50.65	4.29	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	433.33	27.08	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	47.65	6.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.95	1.80	4.96
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	67.46	11.51	4.36
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	66.86	6.50	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	56.38	7.95	7.19
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	66.48	11.08	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	36.61	1.31	3.92
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.90	4.98	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	66.14	5.29	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	66.48	6.65	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	53.57	4.96	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	78.10	4.98	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	49.90	8.77	7.56
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.23	4.20	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	65.73	14.91	6.10
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	132.85	10.22	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	32.31	2.44	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	60.74	1.26	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	51.75	4.54	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	68.04	5.54	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	329.89	83.89	71.42
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	156.79	15.17	5.06
Myoblast, donor1	11241-116D8	34.29	1.49	0.37
Myoblast, donor2	11322-117D8	51.02	3.64	1.34
Myoblast, donor3	11398-118D3	20.01	1.18	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	46.55	3.94	1.17
Natural Killer Cells, donor1	11230-116C6	29.52	2.77	1.54
Natural Killer Cells, donor2	11311-117C6	50.06	2.71	0.60
Natural Killer Cells, donor3	11387-118C1	41.41	4.23	2.21
Neural stem cells, donor1	11275-116H6	175.30	15.97	5.81
Neural stem cells, donor2	11352-117H2	46.22	26.96	3.85
Neurons, donor1	11494-119E9	51.21	10.24	13.65
Neurons, donor2	11574-120E8	12.33	1.32	0.22
Neurons, donor3	11655-122E8	86.33	9.87	7.40
Neutrophils, donor1	11233-116C9	23.20	0.93	0.00
Neutrophils, donor2	11314-117C9	46.38	5.80	8.70
Neutrophils, donor3	11390-118C4	7.33	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	6.65	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	20.84	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	8.02	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	45.70	3.99	1.38
Olfactory epithelial cells, donor2	11934-125I8	72.95	6.51	1.01
Olfactory epithelial cells, donor3	11935-125I9	49.94	2.84	1.25
Olfactory epithelial cells, donor4	11936-126A1	50.26	2.53	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	22.27	3.01	0.60
Osteoblast - differentiated, donor1	11276-116H7	3.62	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	6.86	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	0.62	0.00
Osteoblast, donor1	11277-116H8	8.40	0.59	0.78
Osteoblast, donor2	11354-117H4	79.36	8.43	3.51
Osteoblast, donor3	11426-118G4	7.11	1.42	0.89
Pancreatic stromal cells, donor1	11249-116E7	21.65	1.35	0.34
Pericytes, donor1	11491-119E6	12.02	1.22	0.00
Pericytes, donor2	11571-120E5	18.79	2.72	0.23
Pericytes, donor3	11652-122E5	26.65	1.83	0.81
Perineurial Cells, donor1	11499-119F5	20.12	0.79	0.23
Perineurial Cells, donor2	11579-120F4	9.48	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.20	2.23	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.08	3.43	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.85	2.46	0.65
Placental Epithelial Cells, donor1	11278-116H9	1.91	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	19.96	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	5.89	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	99.37	7.91	0.00
Preadipocyte - breast, donor1	11467-119B9	33.02	1.31	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	0.52	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	30.17	1.35	0.00
Preadipocyte - omental, donor1	11468-119C1	29.73	1.60	0.75
Preadipocyte - omental, donor2	11329-117E6	28.37	3.06	1.75
Preadipocyte - omental, donor3	11403-118D8	40.68	3.87	0.86
Preadipocyte - perirenal, donor1	11469-119C2	19.69	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	7.06	1.84	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	139.54	8.32	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	36.61	3.41	0.68
Preadipocyte - visceral, donor1	11280-116I2	75.64	5.22	1.86
Preadipocyte - visceral, donor2	11357-117H7	111.82	9.66	3.22
Preadipocyte - visceral, donor3	11429-118G7	52.56	1.88	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	38.92	1.66	0.60
Prostate Epithelial Cells, donor2	11331-117E8	49.29	3.93	1.22
Prostate Epithelial Cells, donor3	11404-118D9	102.08	7.72	5.27
Prostate Stromal Cells, donor1	11254-116F3	24.15	1.37	0.11
Prostate Stromal Cells, donor2	11332-117E9	87.32	5.20	0.72
Prostate Stromal Cells, donor3	11405-118E1	27.11	1.88	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.93	2.92	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	23.64	1.11	0.35
Renal Epithelial Cells, donor1	11517-119H5	22.32	2.03	0.00
Renal Epithelial Cells, donor2	11597-120H4	52.64	6.40	0.71
Renal Epithelial Cells, donor3	11678-122H4	36.31	1.38	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	1.36	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	50.27	4.99	1.48
Renal Glomerular Endothelial Cells, donor3	11675-122H1	23.98	1.55	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.29	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	18.93	1.54	0.22
Renal Mesangial Cells, donor2	11598-120H5	45.14	2.51	1.88
Renal Mesangial Cells, donor3	11679-122H5	13.59	0.83	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	44.56	1.88	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.30	2.11	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	30.86	1.35	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.78	1.56	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	41.22	3.41	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	3.09	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.33	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.75	2.54	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	203.70	40.20	32.16
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	385.26	50.63	23.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	172.28	55.69	52.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	23.66	1.95	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	49.45	2.58	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	28.44	0.67	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	63.39	6.57	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	63.52	2.91	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	147.00	6.24	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	55.45	4.65	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	57.48	3.18	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	14.69	1.08	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	74.60	8.61	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	60.53	3.11	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	87.40	3.54	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	66.91	6.31	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	37.92	2.61	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	80.61	3.57	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	57.33	5.57	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	42.54	2.63	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	203.75	10.31	6.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	53.29	4.49	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	133.99	7.29	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	60.33	4.44	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	46.68	4.19	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.31	2.94	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	55.34	3.90	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	93.41	13.44	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	65.87	3.57	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	77.87	4.21	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	51.22	5.81	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	83.62	3.98	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	55.15	2.92	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	63.52	6.06	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.95	2.21	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	87.72	5.98	2.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	61.90	9.11	3.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	34.16	1.92	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	68.79	4.76	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	62.38	5.79	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.18	5.62	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	37.32	3.47	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	49.91	6.91	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	59.53	3.33	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.98	6.05	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	49.16	3.96	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	242.46	13.97	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	46.84	3.32	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	64.74	7.59	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	20.09	0.58	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	3.65	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.57	7.23	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	161.50	9.95	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	131.50	9.88	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	30.23	2.83	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	74.28	5.55	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	127.41	17.43	6.61
Schwann Cells, donor1	11498-119F4	32.91	4.70	0.38
Schwann Cells, donor2	11578-120F3	37.43	0.00	0.00
Schwann Cells, donor3	11659-122F3	23.22	1.97	0.22
Sebocyte, donor1	11220-116B5	29.58	1.10	0.00
Sebocyte, donor2	11301-117B5	59.74	5.06	1.38
Sebocyte, donor3	11378-118B1	30.71	3.71	1.03
Sertoli Cells, donor1	11255-116F4	24.85	1.66	0.00
Sertoli Cells, donor2	11333-117F1	76.26	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.99	1.32	0.35
Skeletal Muscle Cells, donor2	11358-117H8	7.95	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	31.89	1.89	0.79
Skeletal Muscle Cells, donor5	11455-119A6	29.28	1.34	1.04
Skeletal Muscle Cells, donor6	11459-119B1	29.24	2.77	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	41.46	1.89	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	53.79	2.71	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.04	4.27	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.76	0.76	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.13	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.53	1.10	0.41
Skin - palm, donor1	10286-104F7	45.66	16.12	32.23
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	81.02	12.69	2.74
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	56.43	16.36	9.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.00	4.15	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	28.36	1.11	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	37.27	3.52	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	46.52	5.50	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	31.55	2.77	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.54	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	141.62	15.34	3.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.96	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.76	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.04	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	55.04	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.13	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	98.19	9.53	1.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	3.20	0.64	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.93	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.63	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.94	1.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.39	1.14	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.35	2.13	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.29	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.15	1.33	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	32.93	2.37	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.25	1.89	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1.39	0.62	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.26	2.09	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.97	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	46.18	1.33	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	61.69	3.82	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.40	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.12	2.38	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.43	2.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	61.61	5.38	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.00	2.03	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	6.48	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	3.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	37.87	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.03	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	1.18	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.08	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.03	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.75	1.78	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.03	1.50	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.24	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.21	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.90	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	1.71	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.77	2.87	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	39.21	2.34	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	64.53	5.44	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	285.08	27.24	4.76
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	161.05	14.13	4.84
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	208.06	16.89	4.67
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	173.18	11.92	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	154.40	15.75	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	181.58	20.06	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	130.58	11.98	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	136.27	7.94	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	100.84	10.08	1.38
Synoviocyte, donor1	11291-117A4	46.29	5.55	1.51
Synoviocyte, donor2	11368-117I9	40.06	2.68	0.50
Synoviocyte, donor3	11440-118H9	100.98	19.21	3.35
Trabecular Meshwork Cells, donor1	11532-120A2	28.23	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.11	1.85	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	9.10	0.86	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	1.93	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	3.44	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	29.65	3.69	1.23
Urethra, donor2	10319-105A4	215.81	23.38	28.77
Urothelial Cells, donor1	11520-119H8	24.44	2.66	0.53
Urothelial Cells, donor2	11600-120H7	52.47	4.41	1.20
Urothelial Cells, donor3	11681-122H7	30.03	3.90	1.15
Urothelial cells, donor0	11216-116B1	23.40	2.67	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	28.75	2.05	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.05	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.36	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	13.77	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	27.39	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	39.72	3.95	0.62
Wilms' tumor cell line:HFWT	10597-108E3	32.56	5.28	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	73.46	1.96	1.68
achilles tendon, donor2	10292-104G4	57.86	8.27	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	207.79	12.75	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	61.76	5.11	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	10.33	2.85	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	132.79	7.35	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	120.58	7.03	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.09	1.06	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	117.87	11.16	4.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	125.58	10.13	4.85
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	131.08	10.62	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	138.62	10.87	3.88
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	108.74	6.07	3.31
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	487.56	50.71	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	52.52	3.25	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	137.22	9.84	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	214.21	16.66	7.01
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	31.60	3.25	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	69.91	6.99	4.94
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	79.81	5.53	4.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.96	2.13	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	33.36	0.91	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	44.77	3.61	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	91.32	7.57	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	76.72	4.00	3.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	20.44	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	80.23	4.14	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	65.42	5.67	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	3.75	7.50
adenocarcinoma cell line:IM95m	10796-110I4	102.44	6.83	1.65
adipose tissue, adult, pool1	10010-101C1	20.48	1.71	0.47
adipose, donor1	10184-103D4	100.28	10.56	1.17
adipose, donor2	10185-103D5	16.63	0.81	0.00
adipose, donor3	10186-103D6	33.76	2.18	0.82
adipose, donor4	10187-103D7	101.41	4.33	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	32.04	2.84	1.58
adrenal gland, adult, pool1	10081-102A9	36.38	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	41.09	1.87	1.73
alveolar cell carcinoma cell line:SW 1573	10708-109H6	105.40	6.07	2.50
amniotic membrane cells, donor1	12235-129G3	26.43	1.62	0.00
amniotic membrane cells, donor2	12236-129G4	8.79	1.01	1.01
amniotic membrane cells, donor3	12237-129G5	34.76	2.36	0.59
amygdala - adult, donor10196	10167-103B5	221.74	21.34	1.19
amygdala, adult, donor10252	10151-102I7	192.63	14.19	7.50
amygdala, newborn, donor10223	10360-105E9	75.85	10.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	12.35	0.76	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	73.03	5.96	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	152.65	33.40	28.06
aorta, adult, pool1	10052-101G7	17.65	1.18	0.39
appendix, adult	10189-103D9	26.00	3.10	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	169.90	10.32	1.72
artery, adult	10190-103E1	110.05	5.43	5.43
astrocytoma cell line:TM-31	10425-106D2	37.81	1.88	0.43
b cell line:RPMI1788	10427-106D4	34.94	2.38	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.59	1.66	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	30.76	1.59	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	21.42	0.84	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	28.52	2.24	1.12
bladder, adult, pool1	10011-101C2	16.40	1.85	0.87
blood, adult, pool1	10053-101G8	31.00	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	1.71	0.00
bone marrow, adult	10192-103E3	489.25	29.02	19.57
brain, adult, donor1	10084-102B3	145.56	19.48	7.18
brain, adult, pool1	10012-101C3	124.50	4.45	1.34
brain, fetal, pool1	10085-102B4	42.74	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	49.89	9.58	5.62
breast carcinoma cell line:MDA-MB-453	10419-106C5	39.69	2.50	1.87
breast, adult, donor1	10080-102A8	38.51	3.16	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	112.43	11.56	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	62.77	4.95	2.47
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	201.44	11.51	5.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	167.04	9.20	5.57
carcinoid cell line:NCI-H1770	10703-109H1	82.75	12.22	5.17
carcinoid cell line:NCI-H727	10735-110B6	77.33	4.81	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	115.35	9.51	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	85.44	6.12	1.33
caudate nucleus - adult, donor10196	10177-103C6	196.88	25.33	4.61
caudate nucleus, adult, donor10252	10164-103B2	195.10	12.05	6.86
caudate nucleus, adult, donor10258	10379-105H1	251.40	34.39	17.58
caudate nucleus, newborn, donor10223	10354-105E3	108.41	14.28	3.66
cerebellum - adult, donor10196	10173-103C2	174.80	26.22	5.83
cerebellum, adult, donor10252	10166-103B4	143.69	9.39	6.62
cerebellum, adult, pool1	10083-102B2	144.19	25.53	16.21
cerebellum, newborn, donor10223	10357-105E6	185.98	14.11	2.49
cerebral meninges, adult	10188-103D8	78.67	7.31	2.52
cerebrospinal fluid, donor2	10294-104G6	209.76	18.27	21.93
cervical cancer cell line:D98-AH2	10552-107I3	39.97	1.58	0.58
cervical cancer cell line:ME-180	10553-107I4	37.62	2.82	0.83
cervix, adult, pool1	10013-101C4	20.37	2.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.61	2.93	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	3.92	2.61
choriocarcinoma cell line:BeWo	10423-106C9	63.38	2.98	1.74
choriocarcinoma cell line:SCH	10785-110H2	71.46	5.17	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	44.12	8.06	1.42
chorionic membrane cells, donor1	12238-129G6	15.96	1.71	0.57
chorionic membrane cells, donor2	12239-129G7	41.66	2.19	0.70
chorionic membrane cells, donor3	12240-129G8	45.06	9.34	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	185.80	9.09	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	60.70	3.07	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	100.31	6.34	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	77.81	6.16	4.88
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	80.06	7.01	5.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	90.81	12.01	4.48
chronic myelogenous leukemia cell line:K562	10454-106G4	235.86	7.95	5.01
chronic myelogenous leukemia cell line:KU812	10409-106B4	49.52	2.09	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	126.63	7.54	1.14
clear cell carcinoma cell line:TEN	10636-108I6	71.48	5.55	1.91
colon carcinoma cell line:CACO-2	10513-107D9	56.38	3.11	0.73
colon carcinoma cell line:COLO-320	10420-106C6	50.17	3.42	0.76
colon, adult, donor1	10082-102B1	114.24	21.42	8.33
colon, adult, pool1	10014-101C5	51.35	4.94	2.82
colon, fetal, donor1	10070-101I7	63.03	18.54	27.81
common myeloid progenitor CMP, donor1	12130-128D6	9.17	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	164.02	9.77	5.10
cord blood derived cell line:COBL-a 24h infection	10453-106G3	68.67	3.02	1.66
cord blood derived cell line:COBL-a untreated	10449-106F8	92.08	4.09	2.40
corpus callosum, adult, pool1	10042-101F6	28.53	4.42	0.55
cruciate ligament, donor2	10295-104G7	95.64	4.86	5.67
diaphragm, fetal, donor1	10069-101I6	134.83	27.29	42.54
diencephalon, adult	10193-103E4	59.04	12.00	2.40
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	301.71	16.99	5.97
ductal cell carcinoma cell line:KLM-1	10438-106E6	110.01	5.39	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	72.70	4.81	2.65
ductus deferens, adult	10196-103E7	64.78	3.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	70.57	18.72	25.92
duodenum, fetal, donor1, tech_rep2	10071-101I8	108.88	5.89	5.15
dura mater, adult, donor1	10041-101F5	9.83	0.41	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	38.42	2.22	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	80.24	3.30	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	19.12	4.32	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	49.04	2.12	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	26.86	4.01	2.16
embryonic pancreas cell line:2C6	10603-108E9	9.19	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	63.69	7.71	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	110.19	6.16	3.44
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	137.98	9.17	3.06
epidermoid carcinoma cell line:A431	10426-106D3	26.90	2.67	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.07	1.32	0.33
epididymis, adult	10197-103E8	28.26	1.88	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	81.96	3.55	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	58.20	4.33	7.47
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	138.00	6.03	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	93.11	6.99	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	101.39	6.72	2.69
esophagus, adult, pool1	10015-101C6	24.00	1.81	1.70
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.15	0.88	0.38
eye - muscle inferior rectus, donor1	10272-104E2	2334.89	350.11	260.77
eye - muscle lateral, donor2	10298-104H1	820.64	79.96	92.58
eye - muscle medial, donor2	10299-104H2	404.79	56.55	55.06
eye - muscle superior, donor2	10297-104G9	682.17	91.72	76.82
eye - vitreous humor, donor1	10268-104D7	26.23	8.74	7.29
eye, fetal, donor1	10054-101G9	28.73	2.29	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	47.83	3.46	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	75.50	3.32	1.66
frontal lobe, adult, pool1	10040-101F4	42.31	2.91	1.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	183.15	10.81	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	30.08	2.38	0.91
gall bladder, adult	10198-103E9	16.90	0.97	1.21
gamma delta positive T cells, donor1	11937-126A2	34.36	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	47.06	2.24	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	61.68	3.38	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	44.49	4.26	1.74
gastric cancer cell line:AZ521	10549-107H9	58.53	3.12	0.82
gastric cancer cell line:GSS	10560-108A2	30.20	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	110.80	8.00	2.06
giant cell carcinoma cell line:LU65	10487-107B1	58.75	3.67	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	29.25	0.42	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	129.70	10.48	6.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	56.79	4.75	2.85
glioblastoma cell line:A172, tech_rep2	10444-106F3	46.91	5.90	2.25
glioblastoma cell line:T98G	10485-107A8	45.69	1.99	0.88
glioma cell line:GI-1	10413-106B8	31.05	1.17	0.29
globus pallidus - adult, donor10196	10175-103C4	231.06	21.14	2.92
globus pallidus, adult, donor10252	10161-103A8	206.75	20.99	9.76
globus pallidus, adult, donor10258	10367-105F7	214.97	57.51	42.45
globus pallidus, newborn, donor10223	10364-105F4	131.10	23.98	6.40
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	47.68	3.84	2.56
hIPS +CCl2, biol_rep1	14383-156B9	179.97	18.36	3.21
hIPS +CCl2, biol_rep2	14384-156C1	225.43	28.35	5.49
hIPS +CCl2, biol_rep3	14385-156C2	186.79	41.87	4.51
hIPS, biol_rep1	14380-156B6	53.18	24.43	0.00
hIPS, biol_rep2	14381-156B7	161.86	30.18	4.12
hIPS, biol_rep3	14382-156B8	244.97	37.52	4.41
hairy cell leukemia cell line:Mo	10712-109I1	103.73	8.33	1.44
heart - mitral valve, adult	10205-103F7	130.65	7.47	2.99
heart - pulmonic valve, adult	10206-103F8	431.17	24.84	20.92
heart - tricuspid valve, adult	10207-103F9	435.47	46.63	26.64
heart, adult, diseased post-infarction, donor1	10050-101G5	131.21	16.53	3.26
heart, adult, diseased, donor1	10051-101G6	249.54	21.29	6.81
heart, adult, pool1	10016-101C7	81.41	15.41	4.37
heart, fetal, pool1	10046-101G1	23.10	1.75	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	32.40	2.47	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	5.95	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	128.18	7.73	3.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	125.86	5.58	3.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	135.92	6.47	3.03
hepatoma cell line:Li-7	10484-107A7	40.82	2.56	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	27.74	2.11	0.90
hippocampus - adult, donor10196	10169-103B7	201.57	18.93	3.79
hippocampus, adult, donor10252	10153-102I9	266.15	17.96	9.39
hippocampus, adult, donor10258	10374-105G5	154.86	38.84	4.98
hippocampus, newborn, donor10223	10363-105F3	62.39	7.75	4.23
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	270.38	21.36	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	119.97	5.89	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	144.47	10.16	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	58.08	4.51	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	52.68	2.84	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	47.83	3.80	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	25.40	2.34	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.10	0.86	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	28.78	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.36	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.88	1.77	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	98.74	5.16	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	124.30	9.33	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	443.36	31.42	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	40.09	2.48	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	39.25	1.74	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	83.46	9.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.23	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.73	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	19.42	1.25	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.64	1.31	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.35	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.08	4.48	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	125.07	4.80	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	104.13	7.42	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	258.46	12.66	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.08	2.82	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	31.67	2.53	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	56.59	2.42	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.79	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	2.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.91	2.05	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	23.78	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	26.50	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	41.00	2.02	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	111.33	7.73	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	210.80	11.59	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	174.15	8.78	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	38.20	2.44	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	159.41	16.27	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	69.50	3.31	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.32	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.75	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.03	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	57.28	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	10.29	1.22	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	42.30	2.42	1.08
immature langerhans cells, donor1	11904-125F5	25.91	2.18	1.45
immature langerhans cells, donor2	11905-125F6	58.62	6.34	1.58
insula, adult, pool1	10039-101F3	42.59	3.79	1.61
keratoacanthoma cell line:HKA-1	10791-110H8	80.64	11.06	5.20
kidney, adult, pool1	10017-101C8	67.29	5.51	2.80
kidney, fetal, pool1	10045-101F9	13.51	0.99	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	23.58	2.27	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	61.66	4.29	1.94
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	32.48	3.67	1.47
left atrium, adult, donor1	10079-102A7	139.48	18.52	26.70
left ventricle, adult, donor1	10078-102A6	207.82	34.89	36.91
leiomyoblastoma cell line:G-402	10721-110A1	63.48	6.57	1.09
leiomyoma cell line:10964C	10569-108B2	51.73	5.75	1.08
leiomyoma cell line:15242A	10570-108B3	77.17	4.89	0.00
leiomyoma cell line:15425	10571-108B4	86.44	3.40	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	6.27	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	129.63	9.09	3.54
liposarcoma cell line:KMLS-1	10782-110G8	38.74	2.81	0.94
liposarcoma cell line:SW 872	10726-110A6	56.17	3.90	0.97
liver, adult, pool1	10018-101C9	59.31	4.54	3.57
liver, fetal, pool1	10086-102B5	33.87	6.58	0.00
locus coeruleus - adult, donor10196	10182-103D2	189.13	13.27	7.73
locus coeruleus, adult, donor10252	10165-103B3	247.11	20.30	9.60
locus coeruleus, adult, donor10258	10375-105G6	318.82	49.94	29.91
locus coeruleus, newborn, donor10223	10362-105F2	161.52	21.03	5.47
lung adenocarcinoma cell line:A549	10499-107C4	22.00	2.08	1.25
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	54.44	4.22	0.66
lung, adult, pool1	10019-101D1	13.82	1.65	0.95
lung, fetal, donor1	10068-101I5	11.99	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	87.06	13.29	19.25
lymph node, adult, donor1	10077-102A5	76.21	9.94	13.25
lymphangiectasia cell line:DS-1	10727-110A7	68.60	4.60	3.95
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	38.34	3.02	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	62.86	0.85	0.00
mature adipocyte, donor1	12231-129F8	17.76	2.22	0.00
mature adipocyte, donor2	12232-129F9	24.70	1.04	0.00
mature adipocyte, donor3	12233-129G1	17.54	1.90	0.24
mature adipocyte, donor4	12234-129G2	24.22	3.42	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	26.92	1.43	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	218.84	9.02	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	222.53	15.63	8.64
medial frontal gyrus, adult, donor10258	10368-105F8	258.28	26.69	5.40
medial frontal gyrus, newborn, donor10223	10352-105E1	126.24	17.49	5.12
medial temporal gyrus - adult, donor10196	10183-103D3	352.18	19.74	8.27
medial temporal gyrus, adult, donor10252	10156-103A3	293.72	18.04	14.43
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	136.76	48.16	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1076.52	416.25	186.60
medial temporal gyrus, newborn, donor10223	10353-105E2	78.61	11.13	3.23
medulla oblongata - adult, donor10196	10174-103C3	164.84	26.61	1.30
medulla oblongata, adult, donor10252	10155-103A2	155.42	13.62	4.80
medulla oblongata, adult, pool1	10038-101F2	32.00	3.51	1.39
medulla oblongata, newborn, donor10223	10361-105F1	75.69	11.46	2.08
medulloblastoma cell line:D283 Med	10838-111E1	125.54	7.53	3.99
medulloblastoma cell line:ONS-76	10759-110E3	44.02	3.30	0.86
melanoma cell line:COLO 679	10514-107E1	48.73	2.30	1.15
melanoma cell line:G-361	10465-106H6	203.33	16.83	7.06
meningioma cell line:HKBMM	10691-109F7	35.10	2.53	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	216.76	22.91	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	89.95	3.89	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	66.90	4.45	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	58.72	3.64	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	163.16	17.81	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	58.72	2.81	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	52.38	3.66	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	84.68	4.86	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.58	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	33.24	2.76	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	30.90	2.92	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	54.69	3.92	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	51.07	3.70	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	57.97	4.28	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	41.10	3.18	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	107.87	6.28	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	62.07	4.70	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	97.41	6.11	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	36.21	2.48	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	142.27	9.80	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	120.83	10.49	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	44.23	2.09	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	54.88	3.06	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.51	2.95	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	122.19	8.01	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	124.62	7.16	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.81	3.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	41.69	2.81	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	32.98	2.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	51.14	2.46	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	34.36	1.41	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	33.51	2.71	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	50.30	4.32	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.61	2.32	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	35.19	0.58	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.34	2.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.17	1.44	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	29.33	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.56	1.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	38.89	2.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	39.09	1.29	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	165.28	30.99	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	20.46	2.27	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	61.11	7.27	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	3.20	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	64.60	9.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	39.65	3.11	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	94.44	6.30	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	43.71	2.98	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	123.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.03	4.15	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	30.46	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	44.97	5.07	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.63	2.41	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	66.63	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	19.96	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	134.31	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.04	3.67	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.05	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	53.65	6.48	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.49	3.12	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	72.18	5.35	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	69.78	4.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	197.74	17.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	64.71	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	110.84	6.93	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	167.10	10.09	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	164.10	12.72	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	55.21	3.63	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	202.79	21.81	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	114.04	16.47	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	43.09	5.46	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	460.94	22.59	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	160.62	17.30	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	27.58	1.39	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.05	0.97	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	114.09	11.20	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	2.32	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.84	0.47	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	27.11	2.55	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	21.37	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	90.11	4.11	2.67
mesothelioma cell line:Mero-25	10850-111F4	41.76	4.31	1.59
mesothelioma cell line:Mero-41	10851-111F5	88.26	10.02	0.73
mesothelioma cell line:Mero-48a	10852-111F6	54.03	5.31	2.44
mesothelioma cell line:Mero-82	10853-111F7	89.35	9.46	3.42
mesothelioma cell line:Mero-83	10854-111F8	82.90	7.49	1.19
mesothelioma cell line:Mero-84	10855-111F9	99.09	8.59	2.53
mesothelioma cell line:Mero-95	10856-111G1	77.43	5.59	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	43.90	2.48	1.82
mesothelioma cell line:NCI-H226	10846-111E9	64.25	5.61	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	48.17	2.05	1.37
mesothelioma cell line:NCI-H28	10845-111E8	125.20	9.42	2.80
mesothelioma cell line:No36	10857-111G2	84.16	3.59	3.91
mesothelioma cell line:ONE58	10858-111G3	61.51	4.88	3.25
migratory langerhans cells, donor1	11901-125F2	36.08	4.61	0.96
migratory langerhans cells, donor2	11902-125F3	15.75	0.85	1.83
migratory langerhans cells, donor3	11903-125F4	29.97	2.33	3.05
mixed mullerian tumor cell line:HTMMT	10689-109F5	122.76	7.84	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	39.42	2.54	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.16	3.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	51.19	3.62	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	75.76	3.88	1.29
myeloma cell line:PCM6	10474-106I6	32.62	1.58	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	43.63	6.59	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	60.41	7.26	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	21.50	1.34	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.53	1.40	0.44
nasal epithelial cells, donor2	12227-129F4	11.59	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	36.35	4.14	2.07
neuroblastoma cell line:NB-1	10539-107G8	52.20	4.49	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	60.95	5.69	0.63
neuroblastoma cell line:NH-12	10555-107I6	87.96	7.64	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	152.06	13.76	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.64	3.80	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	95.80	5.84	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	57.85	10.17	6.36
neurofibroma cell line:Hs 53.T	10729-110A9	29.81	2.40	0.80
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	30.78	1.86	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.82	1.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	30.78	4.17	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	38.36	2.36	1.58
nucleus accumbens, adult, pool1	10037-101F1	39.56	4.97	1.78
occipital cortex - adult, donor10196	10172-103C1	214.28	18.54	4.12
occipital cortex, adult, donor10252	10163-103B1	289.56	24.69	11.54
occipital cortex, newborn, donor10223	10355-105E4	76.06	5.10	2.18
occipital lobe, adult, donor1	10076-102A4	224.61	38.05	31.23
occipital lobe, fetal, donor1	10073-102A1	85.39	18.02	22.31
occipital pole, adult, pool1	10036-101E9	29.17	2.52	0.47
olfactory region, adult	10195-103E6	159.15	12.42	4.39
optic nerve, donor1	10277-104E7	172.09	48.03	18.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	73.24	3.99	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	55.50	3.16	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	137.49	8.64	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	34.54	4.04	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	32.92	2.06	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	18.69	6.54	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	36.26	3.18	0.85
ovary, adult, pool1	10020-101D2	13.45	0.70	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	84.51	7.88	2.20
pancreas, adult, donor1	10049-101G4	45.15	4.70	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.03	1.68	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	187.22	7.33	2.56
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	22.52	1.99	0.99
paracentral gyrus, adult, pool1	10035-101E8	42.01	2.75	1.01
parietal cortex, adult, donor10258	10373-105G4	195.25	24.96	5.87
parietal lobe - adult, donor10196	10171-103B9	151.42	15.99	2.82
parietal lobe, adult, donor10252	10157-103A4	336.91	25.08	15.68
parietal lobe, adult, pool1	10034-101E7	36.39	3.00	1.15
parietal lobe, fetal, donor1	10072-101I9	203.67	38.79	45.58
parietal lobe, newborn, donor10223	10356-105E5	91.60	11.96	4.86
parotid gland, adult	10199-103F1	21.58	1.85	1.23
penis, adult	10200-103F2	114.94	8.06	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	37.93	2.97	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	71.10	5.97	0.87
pineal gland - adult, donor10196	10179-103C8	64.50	10.97	2.58
pineal gland, adult, donor10252	10160-103A7	45.01	8.29	4.15
pineal gland, adult, donor10258	10377-105G8	152.38	11.29	12.54
pituitary gland - adult, donor10196	10180-103C9	76.90	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	56.81	2.61	1.04
pituitary gland, adult, donor10258	10378-105G9	162.59	22.13	22.13
placenta, adult, pool1	10021-101D3	22.68	1.40	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	56.81	3.18	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	24.44	2.33	0.93
pons, adult, pool1	10033-101E6	47.42	4.82	1.29
postcentral gyrus, adult, pool1	10032-101E5	38.36	3.14	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	106.62	5.68	2.33
prostate cancer cell line:PC-3	10439-106E7	126.14	8.35	4.17
prostate, adult, pool1	10022-101D4	13.15	1.36	0.45
putamen, adult, donor10196	10176-103C5	214.82	17.23	7.32
putamen, adult, donor10252	10152-102I8	247.05	47.06	11.76
putamen, adult, donor10258, tech_rep1	10372-105G3	150.81	49.18	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	179.76	18.85	2.17
putamen, newborn, donor10223	10365-105F5	125.19	10.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	59.06	6.40	3.49
rectum, fetal, donor1	10067-101I4	54.25	13.91	19.47
renal cell carcinoma cell line:OS-RC-2	10411-106B6	69.75	3.39	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	42.25	2.49	1.66
retina, adult, pool1	10030-101E3	28.03	2.29	0.30
retinoblastoma cell line:Y79	10475-106I7	95.09	6.50	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	57.54	4.30	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	43.87	5.91	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	26.52	3.79	3.03
salivary acinar cells, donor1	11771-123I7	66.52	6.15	1.94
salivary acinar cells, donor2	11772-123I8	84.40	5.23	4.27
salivary acinar cells, donor3	11773-123I9	52.30	21.85	16.55
salivary gland, adult, pool1	10093-102C3	21.73	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	71.50	4.55	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	93.22	4.82	3.17
seminal vesicle, adult	10201-103F3	72.48	5.82	5.82
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.78	5.59	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.98	1.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	190.67	5.02	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	126.93	7.79	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	40.67	2.54	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	132.51	9.68	2.06
skeletal muscle - soleus muscle, donor1	10282-104F3	675.29	81.57	40.43
skeletal muscle, adult, pool1	10023-101D5	28.19	3.00	1.68
skeletal muscle, fetal, donor1	10066-101I3	76.38	22.11	15.08
skin, adult, donor1	10074-102A2	27.14	0.00	0.00
skin, fetal, donor1	10065-101I2	34.09	5.68	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.03	3.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	324.35	26.48	6.62
small cell lung carcinoma cell line:DMS 144	10841-111E4	63.61	6.75	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	49.28	3.79	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	63.37	5.31	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	146.00	7.63	0.44
small intestine, adult, pool1	10024-101D6	50.64	4.66	1.91
small intestine, fetal, donor1	10064-101I1	58.97	5.90	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	275.43	16.41	5.13
smooth muscle, adult, pool1	10048-101G3	44.71	5.17	1.29
somatostatinoma cell line:QGP-1	10781-110G7	28.41	1.88	1.07
spinal cord - adult, donor10196	10181-103D1	150.03	12.39	5.05
spinal cord, adult, donor10252	10159-103A6	61.90	5.13	2.76
spinal cord, adult, donor10258	10369-105F9	285.71	71.95	6.92
spinal cord, fetal, donor1	10056-101H2	59.15	14.03	0.00
spinal cord, newborn, donor10223	10359-105E8	128.58	23.88	7.35
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	33.75	1.79	0.30
spleen, adult, pool1	10025-101D7	12.89	1.32	0.66
spleen, fetal, pool1	10044-101F8	6.20	0.87	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	61.49	3.21	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	41.39	4.56	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	252.30	13.63	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	60.20	3.91	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	83.97	4.84	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	153.34	11.01	6.78
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	121.42	2.96	3.38
stomach, fetal, donor1	10062-101H8	18.16	3.20	1.07
submaxillary gland, adult	10202-103F4	56.97	7.41	2.85
substantia nigra - adult, donor10196	10178-103C7	5373.14	1139.76	325.64
substantia nigra, adult, donor10252	10158-103A5	152.04	13.50	5.40
substantia nigra, adult, donor10258	10371-105G2	322.25	66.21	5.17
substantia nigra, newborn, donor10223	10358-105E7	134.25	16.96	7.07
synovial sarcoma cell line:HS-SY-II	10441-106E9	149.48	7.80	3.67
temporal lobe, adult, pool1	10031-101E4	50.78	3.14	1.61
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	68.38	15.67	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.47	7.03	1.76
tenocyte, donor1	11763-123H8	68.77	4.19	0.70
tenocyte, donor2	11765-123I1	46.16	3.43	1.14
tenocyte, donor3	11768-123I4	54.49	6.30	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	89.91	6.97	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	114.99	9.09	1.85
teratocarcinoma cell line:PA-1	10807-111A6	37.50	2.63	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	62.33	4.32	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	134.25	19.29	7.94
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	110.04	11.78	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	330.59	12.70	6.19
testis, adult, pool1	10026-101D8	16.00	1.93	0.75
testis, adult, pool2	10096-102C6	154.72	16.24	5.41
thalamus - adult, donor10196	10168-103B6	207.55	27.60	5.52
thalamus, adult, donor10252	10154-103A1	218.48	14.07	9.06
thalamus, adult, donor10258, tech_rep1	10370-105G1	150.88	117.01	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	480.56	41.50	18.77
thalamus, newborn, donor10223	10366-105F6	77.67	14.96	5.75
throat, adult	10209-103G2	70.16	5.49	1.50
throat, fetal, donor1	10061-101H7	39.61	4.88	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	130.57	5.17	2.78
thymus, adult, pool1	10027-101D9	11.53	0.40	0.50
thymus, fetal, pool1	10043-101F7	7.27	0.94	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	41.75	1.06	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	37.30	3.35	0.70
thyroid, adult, pool1	10028-101E1	15.68	1.49	0.56
thyroid, fetal, donor1	10060-101H6	65.39	8.44	5.27
tongue epidermis (fungiform papillae), donor1	10288-104F9	258.69	21.56	21.56
tongue, adult	10203-103F5	117.92	5.81	3.72
tongue, fetal, donor1	10059-101H5	106.41	12.61	11.43
tonsil, adult, pool1	10047-101G2	11.02	0.80	0.30
trachea, adult, pool1	10029-101E2	12.43	1.31	0.41
trachea, fetal, donor1	10058-101H4	31.93	4.23	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	76.52	4.61	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	42.76	2.33	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	68.63	3.29	1.25
tridermal teratoma cell line:HGRT	10694-109G1	9.51	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	27.34	1.52	0.76
umbilical cord, fetal, donor1	10057-101H3	60.51	10.43	4.17
uterus, adult, pool1	10100-102D1	13.65	2.05	0.34
uterus, fetal, donor1	10055-101H1	13.31	0.00	1.02
vagina, adult	10204-103F6	18.09	4.52	3.88
vein, adult	10191-103E2	30.69	3.07	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	47.80	4.54	1.07

Property "Nearest transcripts" (as page type) with input value "X55654:-75 Y17175:108 AY211920:-141 AB019563:-177 ENST00000361739.1:-198 X15759:-198 BC013387:-198 BC013388:-198 BC013390:-198 BC013391:-198 LP790438:-198 LP790411:-198 LP790412:-198 LP803417:-198 LP803418:-198 LY485908:-198 LY485909:-198 LP790403:-198 LP790404:-198 LP790405:-198 LP803409:-198 LP803410:-198 LP803411:-198 LY485900:-198 LY485901:-198 LY485902:-198 X64709:444" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.